Resected pancreatic cancer outcomes in the elderly

Area of Science:

• Oncology
• Surgical Oncology
• Geriatric Oncology

Background:

• Pancreatic head cancer is a significant cause of cancer mortality.
• Optimal management strategies for elderly patients with pancreatic cancer are still debated.
• Understanding age-related outcomes is crucial for personalized treatment planning.

Purpose of the Study:

• To investigate the impact of age on outcomes in patients with resected pancreatic head cancer.
• To compare survival rates, complications, and treatment patterns between elderly and younger patient cohorts.

Main Methods:

• A retrospective analysis of a pancreatic cancer database from 2000-2012.
• Kaplan-Meier and log-rank analyses for overall survival (OS) curves.
• Cox proportional hazard models for multivariate analysis of prognostic factors.

Main Results:

• 193 patients with resected pancreatic head cancer were analyzed.
• Elderly patients (≥70 years) received less adjuvant therapy (p=0.002).
• No significant differences in overall survival, post-operative complications, or mortality were observed between age groups. Trends suggested increased pancreatic leaks in older patients (p=0.06).
• Lower tumor stage, N0 status, post-operative CA19-9 <90, and adjuvant therapy use were associated with improved OS.

Conclusions:

• Age is not a significant prognostic factor for patients with resected pancreatic head cancer.
• Elderly patients experience similar survival and complication profiles despite reduced adjuvant treatment.
• Treatment decisions should focus on individual patient factors rather than age alone.